FOXO4 10mg

£69.99

FOXO4-DRI is a cell-permeable D-retro-inverso peptide used to study the FOXO4–p53 protein–protein interaction and apoptosis signalling in cell models.

  • OP Labs formerly Oxford Peptides
  • Batch tested Purity: ≥ 99% (HPLC)
  • CAS Number: N/A
  • Peptide Type: Synthetic FOXO4-derived peptide fragment

In stock

Add to Cart
OP Labs FOXO4-DRI 10mg research peptide in glass vial
FOXO4 10mg
£69.99

Free shipping on orders over £20

  • Royal Mail Tracked24
  • Order before 16.00 for same day dispatch
  • Dedicated customer support
  • Guaranteed safe checkout

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

  • OP Labs formerly Oxford Peptides
  • Batch HPLC tested at ≥ 99% purity
  • Storage: –20 °C long term; 2–8 °C short term
  • Sold for research purposes only

FOXO4 Peptide (FOXO4-DRI)

Synonyms: FOXO4-DRI, FOXO4 inhibitory peptide, FOXO4 decoy peptide
CAS Number: N/A
Peptide Classification: Synthetic modified peptide; protein–protein interaction inhibitor
Molecular Formula: C228H388N86O64
Molecular Weight: 5358.05 g/mol
Appearance: White to off-white lyophilised powder
Purity: ≥ 99% (HPLC, typical)
Solubility: Soluble in water and buffered aqueous solutions
Storage: –20 °C, desiccated, protected from light
Pack Size: 10mg

Description & Mechanism

FOXO4-DRI is a synthetic, modified peptide derived from regions of the Forkhead box O4 (FOXO4) transcription factor. It was engineered using a D-retro-inverso design to improve stability and resistance to proteolytic degradation in experimental systems.

In biochemical and cellular research models, FOXO4-DRI has been used to study protein–protein interactions between FOXO4 and p53. The peptide acts as a competitive inhibitor of this interaction, enabling investigation of transcriptional regulation, apoptosis and stress-response signalling. Observed effects are dependent on experimental design, concentration, and model system, and are used for mechanistic exploration rather than defined biological outcomes.

Applications in Research

• Investigation of FOXO4–p53 protein–protein interactions
• Study of apoptosis signalling and transcription factor regulation
• In vitro models examining stress-response signalling pathways
• Use as a research tool in cell-cycle biology studies

Specifications Summary

Purity: ≥ 99% (HPLC)
Appearance: White to off-white lyophilised powder
Peptide Type: Synthetic modified research peptide
Molecular Weight: 5358.05 g/mol
Solubility: Water, buffered aqueous solutions
Storage: –20 °C, desiccated, protected from light

Precautions & Notes

• Intended strictly for laboratory research use
• Not for human or veterinary application
• Experimental outcomes may vary depending on model system and assay design
• Appropriate controls are recommended to interpret pathway-specific effects

References

Calnan D.R., Brunet A. The FoxO code. Oncogene, 2008.
https://pubmed.ncbi.nlm.nih.gov/18391970/

Keywords: FOXO4, FOXO4-DRI, FOXO4 peptide, p53 interaction inhibitor